ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Tax Provision
ADC Therapeutics SA
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Tax Provision
-$39.1m
|
CAGR 3-Years
-407%
|
CAGR 5-Years
-187%
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Tax Provision
-CHf10k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Tax Provision
-$2.9m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Tax Provision
-CHf10k
|
CAGR 3-Years
43%
|
CAGR 5-Years
45%
|
CAGR 10-Years
10%
|
|
Idorsia Ltd
SIX:IDIA
|
Tax Provision
-CHf7.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-111%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Tax Provision
-CHf380k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Tax Provision?
Tax Provision
-39.1m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Tax Provision amounts to -39.1m USD.
What is ADC Therapeutics SA's Tax Provision growth rate?
Tax Provision CAGR 5Y
-187%
Over the last year, the Tax Provision growth was -3 455%. The average annual Tax Provision growth rates for ADC Therapeutics SA have been -407% over the past three years , -187% over the past five years .